Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Heather Eliassen, Sc.D.

Co-Author

This page shows the publications co-authored by A Eliassen and Bernard Rosner.
Connection Strength

7.321
  1. Plasma Metabolomics and Breast Cancer Risk over 20 Years of Follow-up among Postmenopausal Women in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2022 Apr 01; 31(4):839-850.
    View in: PubMed
    Score: 0.249
  2. Dietary and Supplemental Vitamin C Intake and Risk of Breast Cancer: Results from the Nurses' Health Studies. J Nutr. 2022 Mar 03; 152(3):835-843.
    View in: PubMed
    Score: 0.247
  3. A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):85-96.
    View in: PubMed
    Score: 0.242
  4. Sugar-Sweetened Beverages, Artificially Sweetened Beverages, and Breast Cancer Risk: Results From 2 Prospective US Cohorts. J Nutr. 2021 09 04; 151(9):2768-2779.
    View in: PubMed
    Score: 0.239
  5. Healthful and Unhealthful Plant-Based Diets and Risk of Breast Cancer in U.S. Women: Results from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 2021 10; 30(10):1921-1931.
    View in: PubMed
    Score: 0.237
  6. Branched-Chain Amino Acids and Risk of Breast Cancer. JNCI Cancer Spectr. 2021 10; 5(5).
    View in: PubMed
    Score: 0.236
  7. Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis. Cancer Res. 2021 08 01; 81(15):4155-4162.
    View in: PubMed
    Score: 0.235
  8. Prospective study of a diabetes risk reduction diet and the risk of breast cancer. Am J Clin Nutr. 2020 12 10; 112(6):1492-1503.
    View in: PubMed
    Score: 0.227
  9. Postdiagnostic Dietary Glycemic Index, Glycemic Load, Dietary Insulin Index, and Insulin Load and Breast Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2021 02; 30(2):335-343.
    View in: PubMed
    Score: 0.226
  10. Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses' Health Studies. Cancer Res. 2020 11 15; 80(22):5134-5143.
    View in: PubMed
    Score: 0.226
  11. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies. Breast Cancer Res. 2019 03 12; 21(1):40.
    View in: PubMed
    Score: 0.201
  12. Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow-up. Int J Cancer. 2019 04 01; 144(7):1496-1510.
    View in: PubMed
    Score: 0.198
  13. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model. Breast Cancer Res Treat. 2017 Nov; 166(1):227-240.
    View in: PubMed
    Score: 0.179
  14. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 2017 05 01; 140(9):2003-2014.
    View in: PubMed
    Score: 0.177
  15. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Cancer Res. 2016 09 15; 76(18):5423-30.
    View in: PubMed
    Score: 0.169
  16. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 2016 05; 25(5):854-60.
    View in: PubMed
    Score: 0.163
  17. Healthy dietary patterns and risk of breast cancer by molecular subtype. Breast Cancer Res Treat. 2016 Feb; 155(3):579-88.
    View in: PubMed
    Score: 0.163
  18. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies. Int J Cancer. 2016 May 15; 138(10):2346-56.
    View in: PubMed
    Score: 0.163
  19. Alcohol consumption and risk of breast cancer by molecular subtype: Prospective analysis of the nurses' health study after 26 years of follow-up. Int J Cancer. 2016 Mar 01; 138(5):1094-101.
    View in: PubMed
    Score: 0.159
  20. Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1174-83.
    View in: PubMed
    Score: 0.155
  21. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat. 2015 Jun; 151(2):415-25.
    View in: PubMed
    Score: 0.154
  22. Plasma carotenoids and risk of breast cancer over 20 y of follow-up. Am J Clin Nutr. 2015 Jun; 101(6):1197-205.
    View in: PubMed
    Score: 0.154
  23. Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women. Breast Cancer Res Treat. 2015 Apr; 150(3):643-53.
    View in: PubMed
    Score: 0.153
  24. Food predictors of plasma carotenoids. Nutrients. 2013 Oct 11; 5(10):4051-66.
    View in: PubMed
    Score: 0.138
  25. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat. 2013 Jun; 139(3):801-9.
    View in: PubMed
    Score: 0.135
  26. Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med. 2010 Oct 25; 170(19):1758-64.
    View in: PubMed
    Score: 0.113
  27. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):2860-8.
    View in: PubMed
    Score: 0.105
  28. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006 Jul 12; 296(2):193-201.
    View in: PubMed
    Score: 0.084
  29. Tubal sterilization in relation to breast cancer risk. Int J Cancer. 2006 Apr 15; 118(8):2026-30.
    View in: PubMed
    Score: 0.082
  30. Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med. 2005 Oct 24; 165(19):2264-71.
    View in: PubMed
    Score: 0.080
  31. Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study. Am J Obstet Gynecol. 2021 Dec 15.
    View in: PubMed
    Score: 0.061
  32. Association of nut consumption with risk of total cancer and 5 specific cancers: evidence from 3 large prospective cohort studies. Am J Clin Nutr. 2021 Sep 28.
    View in: PubMed
    Score: 0.060
  33. Reliability of a computational platform as a surrogate for manually interpreted immunohistochemical markers in breast tumor tissue microarrays. Cancer Epidemiol. 2021 10; 74:101999.
    View in: PubMed
    Score: 0.059
  34. Consumption of sugar-sweetened and artificially sweetened beverages and breast cancer survival. Cancer. 2021 08 01; 127(15):2762-2773.
    View in: PubMed
    Score: 0.058
  35. Post-diagnostic coffee and tea consumption and breast cancer survival. Br J Cancer. 2021 05; 124(11):1873-1881.
    View in: PubMed
    Score: 0.058
  36. Circulating carotenoids and breast cancer among high-risk individuals. Am J Clin Nutr. 2021 03 11; 113(3):525-533.
    View in: PubMed
    Score: 0.058
  37. Early-Life and Adult Adiposity, Adult Height, and Benign Breast Tissue Composition. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):608-615.
    View in: PubMed
    Score: 0.057
  38. Associations of aspirin and other anti-inflammatory medications with mammographic breast density and breast cancer risk. Cancer Causes Control. 2020 Sep; 31(9):827-837.
    View in: PubMed
    Score: 0.055
  39. A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk. Cancer Res. 2020 03 15; 80(6):1357-1367.
    View in: PubMed
    Score: 0.053
  40. Early-Life and Adult Anthropometrics in Relation to Mammographic Image Intensity Variation in the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev. 2020 02; 29(2):343-351.
    View in: PubMed
    Score: 0.053
  41. Urinary PGE-M Levels and Risk of Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2019 11; 28(11):1845-1852.
    View in: PubMed
    Score: 0.052
  42. Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II. Cancer Causes Control. 2019 Sep; 30(9):943-953.
    View in: PubMed
    Score: 0.051
  43. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies. J Natl Cancer Inst. 2019 07 01; 111(7):700-708.
    View in: PubMed
    Score: 0.051
  44. Night shift work before and during pregnancy in relation to depression and anxiety in adolescent and young adult offspring. Eur J Epidemiol. 2019 Jul; 34(7):625-635.
    View in: PubMed
    Score: 0.051
  45. Maternal rotating night shift work before pregnancy and offspring stress markers. Physiol Behav. 2019 08 01; 207:185-193.
    View in: PubMed
    Score: 0.051
  46. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women. Breast Cancer Res Treat. 2019 Jul; 176(1):191-203.
    View in: PubMed
    Score: 0.051
  47. Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folic acid fortification in the United States. Int J Cancer. 2019 04 15; 144(8):1929-1940.
    View in: PubMed
    Score: 0.050
  48. Pre-diagnostic sex hormone levels and survival among breast cancer patients. Breast Cancer Res Treat. 2019 Apr; 174(3):749-758.
    View in: PubMed
    Score: 0.050
  49. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. JAMA Oncol. 2018 12 01; 4(12):1675-1682.
    View in: PubMed
    Score: 0.049
  50. Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages. Cancer Epidemiol Biomarkers Prev. 2018 12; 27(12):1509-1517.
    View in: PubMed
    Score: 0.049
  51. Androgen receptor expression in normal breast tissue and subsequent breast cancer risk. NPJ Breast Cancer. 2018; 4:33.
    View in: PubMed
    Score: 0.049
  52. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. Cancer Res. 2018 10 15; 78(20):6011-6021.
    View in: PubMed
    Score: 0.049
  53. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med. 2018 09; 15(9):e1002644.
    View in: PubMed
    Score: 0.049
  54. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod. 2018 06 01; 33(6):1175-1182.
    View in: PubMed
    Score: 0.048
  55. Cigarette Smoking and Risk of Early Natural Menopause. Am J Epidemiol. 2018 04 01; 187(4):696-704.
    View in: PubMed
    Score: 0.047
  56. Circulating Hormones and Mammographic Density in Premenopausal Women. Horm Cancer. 2018 04; 9(2):117-127.
    View in: PubMed
    Score: 0.046
  57. Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue. NPJ Breast Cancer. 2017; 3:39.
    View in: PubMed
    Score: 0.046
  58. Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses' Health Studies. Am J Epidemiol. 2017 Sep 01; 186(5):532-540.
    View in: PubMed
    Score: 0.045
  59. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk. Breast Cancer Res Treat. 2016 12; 160(3):547-562.
    View in: PubMed
    Score: 0.043
  60. History of Gestational Diabetes Mellitus and Risk of Incident Invasive Breast Cancer among Parous Women in the Nurses' Health Study II Prospective Cohort. Cancer Epidemiol Biomarkers Prev. 2017 03; 26(3):321-327.
    View in: PubMed
    Score: 0.043
  61. Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies. Cancer Prev Res (Phila). 2016 Sep; 9(9):732-8.
    View in: PubMed
    Score: 0.042
  62. Physical activity from menarche to first pregnancy and risk of breast cancer. Int J Cancer. 2016 09 15; 139(6):1223-30.
    View in: PubMed
    Score: 0.041
  63. Endogenous sex hormones and cognitive function in older women. Alzheimers Dement. 2016 07; 12(7):758-65.
    View in: PubMed
    Score: 0.041
  64. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.040
  65. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. Cancer Epidemiol Biomarkers Prev. 2015 Jun; 24(6):962-8.
    View in: PubMed
    Score: 0.038
  66. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat. 2015 Jan; 149(2):479-87.
    View in: PubMed
    Score: 0.038
  67. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer. J Clin Oncol. 2014 Oct 01; 32(28):3111-7.
    View in: PubMed
    Score: 0.037
  68. Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies. Breast Cancer Res Treat. 2014 Jul; 146(2):383-92.
    View in: PubMed
    Score: 0.036
  69. A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Res. 2013 Aug 01; 73(15):4810-9.
    View in: PubMed
    Score: 0.034
  70. Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):927-36.
    View in: PubMed
    Score: 0.033
  71. ß-Carotene 15,15'-monooxygenase 1 single nucleotide polymorphisms in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr. 2012 Dec; 96(6):1379-89.
    View in: PubMed
    Score: 0.032
  72. Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women. Breast Cancer Res Treat. 2012 Nov; 136(1):277-87.
    View in: PubMed
    Score: 0.032
  73. The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. Int J Cancer. 2010 Jan 01; 126(1):199-207.
    View in: PubMed
    Score: 0.027
  74. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res. 2004 Sep 15; 64(18):6814-9.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.